A risky but … Biotech opportunity

ALDX (Aldeyra Therapeutics) is a small market cap biotech name with some very big potential.

Our quantamental radar pick it up as a multi bagger play if there is a Phase 3 catalyst in place. Something that’s expected very soon. Currently at 7.14 , has a potential to shoot up and even double or triple in the next months. Of course all the biotech names are double edge swords and position sizing must take place according to each investor’s unique profile , considering the overall portfolio structure as well.